A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

A prostate biopsy involves removing prostate tissue to test for cancer. Learn about types, procedure, risks, and follow-up ...

NICE recommendation of darolutamide plus hormone therapy for metastatic prostate cancer offers around 6000 patients in ...

A new, pioneering procedure was used to treat a record number of prostate patients in a day. Frimley Health NHS Foundation ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...

Most of the patients were able to go home hours after their treatment for enlarged prostate. | ITV News Meridian ...

BERLIN — For men with high-risk biochemically recurrent prostate cancer, adding enzalutamide (Xtandi) to standard androgen ...

Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...

The National Institute for Health and Care Excellence ( Nice) has given the green light for a new “gentler” treatment for ...